CGF疗法:通过IL-17通路将androgenetic alopecia的观察结果与牛皮的治疗联系起来
Qin Xiao1, Weifang Chu1, Jing Guo1
1Department of Dermatology, Shanghai East Hospital, Tongji University School of Medicine, 150 hao, Jimo Road, Shanghai, 200120, China.
Stem cell research & therapy
|October 8, 2024
概括
缩生长因子 (CGF) 在患者和牛皮小鼠模型中有效降低了IL-17水平. CGF表现出显著的抗炎作用,为牛皮提供了有前途的新疗法,特别是在治疗耐药病例中.
科学领域:
- 再生医学是一种再生医学.
- 免疫皮肤学 免疫皮肤学
- 干细胞疗法是一种干细胞疗法.
背景情况:
- 富含CD34+干细胞的缩生长因子 (CGF) 用于色脱发和皮肤复发.
- 牛皮带来了治疗挑战,特别是在不适合生物制剂的患者中.
- CGF的免疫调节特性表明,它有可能用于治疗牛皮.
研究的目的:
- 评估CGF在治疗牛皮方面的治疗潜力.
- 评估CGF对androgenetic脱发症患者和牛皮病小鼠模型中Interleukin-17 (IL-17) 水平的影响.
主要方法:
- 血清IL-17水平测定在12名接受CGF治疗雄激素脱发症的患者中.
- 一个牛皮病小鼠模型被CGF治疗,评估了牛皮病区域和严重性指数 (PASI) 评分,皮肤屏障功能和组织学.
- 在体外研究中,研究了CGF对角质细胞和炎症标志物的作用 (TNF-α,IFN-γ,IL-23,IL-17).
主要成果:
- CGF注射显著降低了安卓发症患者的血清IL-17.
- 在牛皮小鼠模型中,CGF治疗改善了PASI得分和皮肤屏障功能.
- 在体外,CGF降低了关键的炎症性细胞因子 (TNF-α,IFN-γ,IL-23,IL-17) 和一个临床病例显示患者对IL-23治疗有抗性的改善.
结论:
- CGF表现出强大的抗炎作用,与牛皮治疗有关.
- 作为多功能性治疗牛皮的选择,CGF显示出前景.
- 对于生物耐药牛皮病变患者来说,CGF特别有价值.
相关概念视频
T Cell Types and Functions
959
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
959
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K


